ADCT
Price
$2.85
Change
+$0.05 (+1.79%)
Updated
Jul 3 closing price
Capitalization
282.8M
36 days until earnings call
CHRS
Price
$0.81
Change
+$0.01 (+1.25%)
Updated
Jul 3 closing price
Capitalization
93.91M
24 days until earnings call
Interact to see
Advertisement

ADCT vs CHRS

Header iconADCT vs CHRS Comparison
Open Charts ADCT vs CHRSBanner chart's image
ADC Therapeutics SA
Price$2.85
Change+$0.05 (+1.79%)
Volume$323.65K
Capitalization282.8M
Coherus Oncology
Price$0.81
Change+$0.01 (+1.25%)
Volume$679.4K
Capitalization93.91M
ADCT vs CHRS Comparison Chart in %
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. CHRS commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and CHRS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ADCT: $2.85 vs. CHRS: $0.81)
Brand notoriety: ADCT and CHRS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 41% vs. CHRS: 49%
Market capitalization -- ADCT: $282.8M vs. CHRS: $93.91M
ADCT [@Biotechnology] is valued at $282.8M. CHRS’s [@Biotechnology] market capitalization is $93.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileCHRS’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • CHRS’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than CHRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 5 TA indicator(s) are bullish while CHRS’s TA Score has 3 bullish TA indicator(s).

  • ADCT’s TA Score: 5 bullish, 4 bearish.
  • CHRS’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, ADCT is a better buy in the short-term than CHRS.

Price Growth

ADCT (@Biotechnology) experienced а +5.56% price change this week, while CHRS (@Biotechnology) price change was +10.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ADCT is expected to report earnings on Nov 11, 2025.

CHRS is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADCT($283M) has a higher market cap than CHRS($93.9M). ADCT YTD gains are higher at: 43.216 vs. CHRS (-41.304). CHRS has higher annual earnings (EBITDA): 80.2M vs. ADCT (-95.64M). ADCT has more cash in the bank: 195M vs. CHRS (82.4M). ADCT has less debt than CHRS: ADCT (123M) vs CHRS (270M). CHRS has higher revenues than ADCT: CHRS (272M) vs ADCT (75.8M).
ADCTCHRSADCT / CHRS
Capitalization283M93.9M301%
EBITDA-95.64M80.2M-119%
Gain YTD43.216-41.304-105%
P/E RatioN/A1.84-
Revenue75.8M272M28%
Total Cash195M82.4M237%
Total Debt123M270M46%
FUNDAMENTALS RATINGS
CHRS: Fundamental Ratings
CHRS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
15

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTCHRS
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
67%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
70%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
77%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEIGY4.370.71
+19.56%
Semperit Ag Holding
RYKKF38.35N/A
N/A
Ryohin Keikaku Co. Ltd.
HBRIY2.63N/A
N/A
Harbour Energy Plc
LCHD0.03N/A
N/A
Leader Capital Holdings Corp.
EBQLF0.40N/A
N/A
EBIQUITY PLC

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+1.79%
QTTB - ADCT
49%
Loosely correlated
N/A
VTYX - ADCT
44%
Loosely correlated
+2.97%
IMNM - ADCT
40%
Loosely correlated
+2.43%
CLRB - ADCT
40%
Loosely correlated
N/A
NRIX - ADCT
40%
Loosely correlated
+2.33%
More

CHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHRS has been loosely correlated with XENE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CHRS jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHRS
1D Price
Change %
CHRS100%
+1.87%
XENE - CHRS
40%
Loosely correlated
-0.33%
ADCT - CHRS
39%
Loosely correlated
+1.79%
ARRY - CHRS
39%
Loosely correlated
+11.93%
AXON - CHRS
38%
Loosely correlated
+2.70%
AMRN - CHRS
35%
Loosely correlated
+0.48%
More